50th Anniversary | COVID Vaccine | Fecal Transplant, Cancer Information Highlights, 02/17/2021

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Observing the 50th Anniversary of the National Cancer Act of 1971
50th anniversary of the National Cancer Act logo   The National Cancer Act of 1971 continues to advance cancer research. Learn why NCI is observing the 50th anniversary of the act during 2021 on Cancer.gov. Read the story of Mary Lasker, whose advocacy led to the passage of the act.
Coronavirus Vaccines and People with Cancer
Dr. Steven Pergam gets his vaccine shot   Many people being treated for cancer are asking whether they should get a COVID-19 vaccine. In this blog post, infectious diseases expert Dr. Steven Pergam explains why people being treated for cancer, their caregivers, and cancer survivors should get the vaccine and when.
Fecal Transplants Help People Respond to Immunotherapy
stylized image of multicolored bacteria in the colon   For people with cancers that do not respond to immunotherapy drugs, the use of fecal transplants to change the gut bacteria may help them respond. Learn about the research in people with melanoma that led to this finding.
Mice Are Reliable Stand-Ins for Human Tumors

There has been concern that experiments using mouse models of human cancer might not reflect what would happen in humans. Now, a large study has provided strong assurance that a type of mouse model, known as PDX mice, does provide meaningful research results.

FDA Approvals
Cemiplimab-rwlc for Basal Cell Carcinoma

Food and Drug Administration approval for cemiplimab-rwlc (Libtayo) now includes treatment of certain people with a type of skin cancer called basal cell carcinoma that is locally advanced or metastatic.
Also of Interest
Kidney (Renal Cell) Cancer

Explore the links on this page to learn more about kidney cancer treatment, statistics, research, and clinical trials.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.